Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Sheppard Pratt Health System, explained in plain language.
This study tested a single 25mg dose of psilocybin in 20 adults with depression that didn't respond to standard treatments and who also had ongoing suicidal thoughts. The goal was to see if the drug is safe and tolerable in this high-risk group. Participants received the dose in …
Phase: PHASE2 • Sponsor: Sheppard Pratt Health System • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC